The Annals Holiday Offer - Save 50%
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 38, No. 1, pp. 46-49. DOI 10.1345/aph.1D222
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolland, M. J
Right arrow Articles by Black, P. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolland, M. J
Right arrow Articles by Black, P. N

Cushing's Syndrome Due to Interaction Between Inhaled Corticosteroids and Itraconazole

Mark J Bolland, MBChB

Registrar, Department of Endocrinology, Auckland Hospital, Auckland, New Zealand

Warwick Bagg, MD

Senior Lecturer in Medicine, Department of Medicine, University of Auckland; Physician, Department of Internal Medicine, Auckland Hospital

Mark G Thomas, MD

Associate Professor of Infectious Diseases, Department of Molecular Medicine and Pathology, University of Auckland; Physician, Department of Infectious Diseases, Auckland Hospital

Jennifer A Lucas, MBChB

Lecturer in Medicine, Department of Medicine, University of Auckland; Physician, Department of Internal Medicine, Auckland Hospital; Research Fellow in Bone Disease, Department of Medicine, University of Auckland

Rob Ticehurst, BSc Hons

Senior Pharmacist, Pharmacy Department, Auckland Hospital

Peter N Black, MBChB

Associate Professor of Medicine and Clinical Pharmacology, Department of Medicine, University of Auckland; Physician, Department of Internal Medicine, Auckland Hospital

Reprints: Mark J Bolland MBChB, Department of Endocrinology, Auckland Hospital, Private Bag 92-024, Auckland 1, New Zealand, fax 64 9 3074993, mbolland{at}adhb.govt.nz

OBJECTIVE: To report a case of an interaction between inhaled corticosteroids and itraconazole causing iatrogenic Cushing's syndrome and provide a review of the relevant literature.

CASE SUMMARY: A 70-year-old white woman on long-term treatment with high-dose inhaled corticosteroids for asthma was diagnosed as having Scedosporium apiospermum infection of the skin and subcutaneous tissues. As a result, she was treated with itraconazole for 2 months. She subsequently developed Cushing's syndrome due to a probable cytochrome P450-mediated interaction between itraconazole and budesonide. She also had secondary adrenal insufficiency requiring prolonged treatment with replacement hydrocortisone.

DISCUSSION: Budesonide is a potent glucocorticoid that is metabolized in the liver by the CYP3A4 isoenzyme to inactive metabolites. Itraconazole is a potent cytochrome P450 inhibitor. It can inhibit the metabolism of oral or inhaled corticosteroids, producing cortisol excess leading to Cushing's syndrome and adrenal insufficiency. An assessment of causality indicated a possible adverse interaction between itraconazole and budesonide.

CONCLUSIONS: The combination of itraconazole and inhaled corticosteroids is increasingly being used to treat conditions such as allergic bronchopulmonary aspergillosis. Clinicians need to be aware of the potential for an interaction between such a combination.

Key Words: budesonide, Cushing's syndrome, itraconazole

Published Online, December 5, 2003. www.theannals.com, DOI 10.1345/aph.1D222


This article has been cited by other articles:


Home page
J Int Assoc Physicians AIDS Care (Chic Ill)Home page
N. Valin, N. De Castro, V. Garrait, A. Bergeron, C. Bouche, and J. M. Molina
Iatrogenic Cushing's Syndrome in HIV-Infected Patients Receiving Ritonavir and Inhaled Fluticasone: Description of 4 New Cases and Review of the Literature
J Int Assoc Physicians AIDS Care (Chic Ill), March 1, 2009; 8(2): 113 - 121.
[Abstract] [PDF]


Home page
The Annals of PharmacotherapyHome page
H W. Kelly
Comparison of Inhaled Corticosteroids: An Update
Ann. Pharmacother., March 1, 2009; 43(3): 519 - 527.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
K. J. Cortez, E. Roilides, F. Quiroz-Telles, J. Meletiadis, C. Antachopoulos, T. Knudsen, W. Buchanan, J. Milanovich, D. A. Sutton, A. Fothergill, et al.
Infections Caused by Scedosporium spp.
Clin. Microbiol. Rev., January 1, 2008; 21(1): 157 - 197.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D R Woods, C S Arun, P A Corris, and P Perros
Cushing's syndrome without excess cortisol.
BMJ, February 25, 2006; 332(7539): 469 - 470.
[Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.